Danapha Pharmaceutical JSC (HSTC:DAN) Total Stockholders Equity: ₫0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HSTC:DAN Danapha Pharmaceutical JSC HSTC:DAN
31 GF Score
Price ₫28,000.00
! 1 Warning Sign
View Full Analysis

What is Danapha Pharmaceutical JSC Total Stockholders Equity?

Danapha Pharmaceutical JSC HSTC:DAN 31 Total Stockholders Equity is ₫0.00 Mil as of . 20. GuruFocus rates HSTC:DAN with a GF Score™ of 31/100. The stock has 1 warning sign investors should review.

Danapha Pharmaceutical JSC's Total Stockholders Equity for the quarter that ended in . 20 was ₫0.00 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Danapha Pharmaceutical JSC's Book Value per Share for the quarter that ended in . 20 was ₫N/A. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Danapha Pharmaceutical JSC's Debt-to-Equity for the quarter that ended in . 20 was .


Danapha Pharmaceutical JSC  (HSTC:DAN) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Danapha Pharmaceutical JSC's Book Value per Share for the quarter that ended in . 20 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Danapha Pharmaceutical JSC's Debt-to-Equity for the quarter that ended in . 20 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Danapha Pharmaceutical JSC Total Stockholders Equity Related Terms


Danapha Pharmaceutical JSC Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Danapha Pharmaceutical JSC's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Danapha Pharmaceutical JSC Total Stockholders Equity Chart

Danapha Pharmaceutical JSC Annual Data
Trend
Total Stockholders Equity

Danapha Pharmaceutical JSC Semi-Annual Data
Total Stockholders Equity
HSTC:DAN
31GF Score
Danapha Pharmaceutical JSC HSTC:DAN
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of ₫0.00 Mil mean?
Danapha Pharmaceutical JSC (HSTC:DAN) has a Total Stockholders Equity of ₫0.00 Mil as of . 20. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Danapha Pharmaceutical JSC and its competitors.
Is Danapha Pharmaceutical JSC's Total Stockholders Equity too high?
Danapha Pharmaceutical JSC's current Total Stockholders Equity is ₫0.00 Mil. Overall, Danapha Pharmaceutical JSC has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Danapha Pharmaceutical JSC's Total Stockholders Equity compare to ZTS and UTHR?
Danapha Pharmaceutical JSC's Total Stockholders Equity of ₫0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Drug Manufacturers company?
A good Total Stockholders Equity depends on the Drug Manufacturers industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Danapha Pharmaceutical JSC and its competitors. Danapha Pharmaceutical JSC's current Total Stockholders Equity is ₫0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Danapha Pharmaceutical JSC stock overvalued right now?
Danapha Pharmaceutical JSC (HSTC:DAN) has a current Total Stockholders Equity of ₫0.00 Mil. The current Total Stockholders Equity is ₫0.00 Mil. Danapha Pharmaceutical JSC's overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Danapha Pharmaceutical JSC (HSTC:DAN), the current Total Stockholders Equity is ₫0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Danapha Pharmaceutical JSC Business Description

Address 253 Dung Si Thanh Khe, Da Nang, VNM
Danapha Pharmaceutical JSC is a manufacturer of herbal medicine and specific drugs such as central nervous system, neurotonics, anti-diabetics, cardiovascular drug, gastrointestinal and heaptic biliary system with forms such as tablets, capsules, injection, sirup, balm and medicated oil.
31GF Score

Get the complete analysis for HSTC:DAN

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫28,000.00
Price